TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
193 hedge funds and large institutions have $5.28B invested in Turning Point Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 93 increasing their positions, 54 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 166 → 193 (+27)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
193
Holding in Top 10
4
Calls
$3.69M
Puts
$1.69M
Top Buyers
| 1 | +$72.4M | |
| 2 | +$68.6M | |
| 3 | +$57.5M | |
| 4 |
BlackRock
New York
|
+$55.4M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$31.1M |
Top Sellers
| 1 | -$28.8M | |
| 2 | -$16.3M | |
| 3 | -$13.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$11.7M |
| 5 |
Renaissance Technologies
New York
|
-$7.68M |